Indaptus Therapeutics Stock (NASDAQ: INDP) stock price, news, charts, stock research, profile.
You can purchase shares of Indaptus Therapeutics (NASDAQ:INDP) through any online brokerage.
Other companies in Indaptus Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN) and Imunon (NASDAQ:IMNN).
Indaptus Therapeutics has a consensus price target of $12.00.
The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $1.24 last updated November 8, 2024 at 4:20 PM EST.
There are no upcoming dividends for Indaptus Therapeutics.
Indaptus Therapeutics’s Q3 earnings are confirmed for Tuesday, November 19, 2024.
There is no upcoming split for Indaptus Therapeutics.
Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.